Hansoh Pharmaceutical Group Co Limited/ADR (HNPHY)

OTC: HNPHY · CIK 0002073669 · United States

Every official Hansoh Pharmaceutical Group Co Limited/ADR filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

Open HNPHY filings

Hansoh Pharmaceutical Group Co Limited/ADR documents

Hansoh Pharmaceutical Group Co Limited/ADR 10-K 2026HNPHY 10-K 2026: annual report for fiscal 2026
Hansoh Pharmaceutical Group Co Limited/ADR 10-K 2025HNPHY 10-K 2025: annual report for fiscal 2025
Hansoh Pharmaceutical Group Co Limited/ADR 10-K 2024HNPHY 10-K 2024: annual report for fiscal 2024
Hansoh Pharmaceutical Group Co Limited/ADR 10-K 2023HNPHY 10-K 2023: annual report for fiscal 2023
Hansoh Pharmaceutical Group Co Limited/ADR 10-K 2022HNPHY 10-K 2022: annual report for fiscal 2022
Hansoh Pharmaceutical Group Co Limited/ADR 10-Q 2026HNPHY 10-Q 2026: quarterly report for fiscal 2026
Hansoh Pharmaceutical Group Co Limited/ADR 10-Q 2025HNPHY 10-Q 2025: quarterly report for fiscal 2025
Hansoh Pharmaceutical Group Co Limited/ADR 10-Q 2024HNPHY 10-Q 2024: quarterly report for fiscal 2024
Hansoh Pharmaceutical Group Co Limited/ADR 10-Q 2023HNPHY 10-Q 2023: quarterly report for fiscal 2023
Hansoh Pharmaceutical Group Co Limited/ADR 10-Q 2022HNPHY 10-Q 2022: quarterly report for fiscal 2022
Hansoh Pharmaceutical Group Co Limited/ADR 8-K 2026HNPHY 8-K 2026: current report for fiscal 2026
Hansoh Pharmaceutical Group Co Limited/ADR 8-K 2025HNPHY 8-K 2025: current report for fiscal 2025
Hansoh Pharmaceutical Group Co Limited/ADR 8-K 2024HNPHY 8-K 2024: current report for fiscal 2024
Hansoh Pharmaceutical Group Co Limited/ADR 8-K 2023HNPHY 8-K 2023: current report for fiscal 2023
Hansoh Pharmaceutical Group Co Limited/ADR 8-K 2022HNPHY 8-K 2022: current report for fiscal 2022
Hansoh Pharmaceutical Group Co Limited/ADR DEF 14A 2026HNPHY DEF 14A 2026: proxy statement for fiscal 2026
Hansoh Pharmaceutical Group Co Limited/ADR DEF 14A 2025HNPHY DEF 14A 2025: proxy statement for fiscal 2025
Hansoh Pharmaceutical Group Co Limited/ADR DEF 14A 2024HNPHY DEF 14A 2024: proxy statement for fiscal 2024
Hansoh Pharmaceutical Group Co Limited/ADR DEF 14A 2023HNPHY DEF 14A 2023: proxy statement for fiscal 2023
Hansoh Pharmaceutical Group Co Limited/ADR DEF 14A 2022HNPHY DEF 14A 2022: proxy statement for fiscal 2022
Hansoh Pharmaceutical Group Co Limited/ADR Form 4 2026HNPHY Form 4 2026: insider trading filing for fiscal 2026
Hansoh Pharmaceutical Group Co Limited/ADR Form 4 2025HNPHY Form 4 2025: insider trading filing for fiscal 2025
Hansoh Pharmaceutical Group Co Limited/ADR Form 4 2024HNPHY Form 4 2024: insider trading filing for fiscal 2024
Hansoh Pharmaceutical Group Co Limited/ADR Form 4 2023HNPHY Form 4 2023: insider trading filing for fiscal 2023
Hansoh Pharmaceutical Group Co Limited/ADR Form 4 2022HNPHY Form 4 2022: insider trading filing for fiscal 2022
Hansoh Pharmaceutical Group Co Limited/ADR S-1 2026HNPHY S-1 2026: registration statement for fiscal 2026
Hansoh Pharmaceutical Group Co Limited/ADR S-1 2025HNPHY S-1 2025: registration statement for fiscal 2025
Hansoh Pharmaceutical Group Co Limited/ADR S-1 2024HNPHY S-1 2024: registration statement for fiscal 2024
Hansoh Pharmaceutical Group Co Limited/ADR S-1 2023HNPHY S-1 2023: registration statement for fiscal 2023
Hansoh Pharmaceutical Group Co Limited/ADR S-1 2022HNPHY S-1 2022: registration statement for fiscal 2022
Hansoh Pharmaceutical Group Co Limited/ADR 13F 2026HNPHY 13F 2026: institutional holdings for fiscal 2026
Hansoh Pharmaceutical Group Co Limited/ADR 13F 2025HNPHY 13F 2025: institutional holdings for fiscal 2025
Hansoh Pharmaceutical Group Co Limited/ADR 13F 2024HNPHY 13F 2024: institutional holdings for fiscal 2024
Hansoh Pharmaceutical Group Co Limited/ADR 13F 2023HNPHY 13F 2023: institutional holdings for fiscal 2023
Hansoh Pharmaceutical Group Co Limited/ADR 13F 2022HNPHY 13F 2022: institutional holdings for fiscal 2022

More companies